Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-24T14:27:08.303Z Has data issue: false hasContentIssue false
  • English
  • Français

A Trial of Propranolol in Chronic Schizophrenia

Published online by Cambridge University Press:  29 January 2018

D. H. Myers ,
P. L. Campbell ,
N. M. Cocks ,
J. A. Flowerdew  and
A. Muir
D. H. Myers
Affiliation:
Royal Shrewsbury Hospital, (Shelton), Shrewsbury, Salop
P. L. Campbell
Affiliation:
Royal Shrewsbury Hospital, (Shelton), Shrewsbury, Salop
N. M. Cocks
Affiliation:
Royal Shrewsbury Hospital, (Shelton), Shrewsbury, Salop
J. A. Flowerdew
Affiliation:
Royal Shrewsbury Hospital, (Shelton), Shrewsbury, Salop
A. Muir
Affiliation:
6 Grangefields Road, Shrewsbury, Salop
Get access Rights & Permissions [Opens in a new window]

Summary

A small (n = 20), double blind, controlled trial failed to show that propranolol has any beneficial effect in chronic schizophrenia.

Type
Papers
Information
The British Journal of Psychiatry , Volume 139 , Issue 2 , August 1981 , pp. 118 - 121
Copyright
Copyright © Royal College of Psychiatrists, 1981 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brown, G. R., Birley, J. L. T. & Wing, J. K. (1972) Influence of family life on the course of schizophrenic disorders: a replication. British Journal of Psychiatry, 121, 241–58.Google Scholar
Gardos, C., Cole, J. O., Volicer, L., Orzack, M. H. & Cole Oliff, A. (1973) A dose-response study of propranolol in chronic schizophrenics. Current Therapeutic Research, 15, 314–23.Google Scholar
Harris, A. D., Letemendia, F. J. J. & Willems, P. J. A. (1967) A rating scale of the mental state: for use in the chronic population of the psychiatric hospital. British Journal of Psychiatry, 113, 941–9.Google Scholar
Lindstrom, L. H. & Persson, E. (1980) Propranolol in chronic schizophrenia: A controlled study in neuroleptic-treated patients. British Journal of Psychiatry, 137, 126–30.CrossRefGoogle ScholarPubMed
Maxwell, A. E. & Pilliner, A. E. G. (1968) Deriving coefficients of reliability and agreement for ratings. The British Journal of Mathematical and Statistical Psychology, 21, Part I, 105–16.CrossRefGoogle ScholarPubMed
Mellor, C. S. (1970) First rank symptoms of schizophrenia. British Journal of Psychiatry, 117, 15—23.CrossRefGoogle ScholarPubMed
Overall, J. E. & Gorhan, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799.Google Scholar
Peet, M., Middlemiss, D. N. & Yates, R. A. (1980) Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients. Lancet, ii, 978.Google Scholar
Sheppard, G. P. (1979) High-dose propranolol in schizophrenia. British Journal of Psychiatry, 134, 470–6.Google Scholar
Wing, J. K., Cooper, J. E. & Sartorius, N. (1974) Measurement and Classification of Psychiatric Symptoms. London: Cambridge University Press.Google Scholar
Yorkston, N. J., Zaki, S. A., Pitcher, D. R., Cruzelier, J. H., Hollander, E. & Sergeant, H. G. S. (1977) Propranolol as an adjunct to the treatment of schizophrenia. Lancet, ii, 575.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.